MedTrace Logo

Premedication Dyclonine Improves Visibility During Bowel Cleansing for Colonoscopy

NCT03352700 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 580

Last updated 2017-11-24

No results posted yet for this study

Summary

In this randomized controlled study, consecutive outpatients scheduled for elective colonoscopy were randomized into two groups. Group A patients (n = 300) used only 3L PEG before colonoscopy. Patients in group B (n = 300) were additionally advised to Dyclonine Hydrochloride Mucilage plus 3L PEG, The overall quality of colonoscopy cleaning was evaluated using the Boston Bowel Preparation Scale by a single endoscopist who was blinded to the intervention. Visibility was blindly assessed for the amount of air bubbles and adenoma detection rate (ADR). Difficulty of procedure, and adverse events were also evaluated.

Conditions

  • Bowel Preparation Scale
  • the Amount of Air Bubble
  • Adenoma Detection Rate

Interventions

DRUG

3L PEG

Group A patients (n = 300) used only 3L PEG before colonoscopy.

DRUG

3L PEG+Dyclonine Hydrochloride Mucilage

Patients in group B (n = 300) were additionally advised to Dyclonine Hydrochloride Mucilage plus 3 L PEG

Sponsors & Collaborators

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Peng Cheng · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2018-01-01
Completion
2018-02-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03352700 on ClinicalTrials.gov